Buy Natco Pharma: LKP Shares

3975 Investors following Natco Pharma. Share this News with them.

0

Like this story, share it with millions of investors on M3

Buy Natco Pharma: LKP Shares

LKP Shares has recommended a buy rating on Natco Pharma. Natco trading at half its book value has robust EBIDTA margins of 22% and the research firm is positive on the longterm prospects at 3xFY'09E earnings.

Post your opinion here

 

0

Tweet

Share on Tumblr

RELATED NEWS Buy Abbott India, target of Rs 540: LKP Shares Buy Shanthi Gears, target of Rs 56: LKP Shares Buy Visaka Inds, target of Rs 55: Sunidhi Securities Accumulate Dabur India, target of Rs 80: Angel Buy Tata Motors, target of Rs 339: Angel ALSO READ See previous views by LKP Shares See what other Experts & Brokerages are saying about Natco Pharma See messages about Natco Pharma Natco Pharma BSE | NSE 30/05/12 Are Mutual Funds betting on Natco Pharma?

LKP Shares has recommended a buy rating on Natco Pharma in its research report. "Although the generic launch of Copaxone used in treatment of multiple sclerosis is more than two years away during which Natco could face litigation from Teva as it is a USD 1.5 billion drug, we believe that the signing of the exclusive supply and distribution agreement with Mylan for the generic version of the drug is a huge long-term positive for Natco. Natco trading at half its book value has robust EBIDTA margins of 22% and we are positive on the longterm prospects at 3xFY'09E earnings. We rate the stock as a BUY," says LKP Shares' research report.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

To read the full report click on the attachment......